The Executive Board of Merck

The Executive Board of Merck KGaA comprises four general partners with personal liability.
Dr. Karl-Ludwig Kley
Dr. Karl-Ludwig Kley  
Chairman of the Executive Board
Dr. Karl-Ludwig Kley
Born in 1951, Lawyer
Member of the Supervisory Board and Board of Partners of Merck from March 2004 to June 2006; Member of the Executive Board since September 2006
Responsibility for Group-wide functions:
Human Resources (global); Legal, Patents, Trademarks; Auditing, Risk Management; Strategic Planning; Inhouse Consulting; Corporate Communications; Environment, Health and Safety; Information Services
 
Dr. Michael Becker
Dr. Michael Becker  
Chief Financial Officer
Dr. Michael Becker
Born in 1948, Lawyer
joined Merck in 1998, Member of the Executive Board since January 2000
Responsibility for Group-wide functions:
Accounting, Controlling, Finance, Taxes, Insurance;
Mergers and Acquisitions; Investor Relations; Purchasing
 
Dr. Bernd Reckmann
Dr. Bernd Reckmann  
Head of the Chemicals business sector
Dr. Bernd Reckmann
Born in 1955, Biochemist
joined Merck in 1986, Member of the Executive Board since January 2007
Responsibility for Group-wide functions:
Chemicals business sector; site management Darmstadt and Gernsheim; Production, Engineering, Process Development
Regional responsibility:
Germany (including Human Resources); Asia; United States (Chemicals); Australia; New Zealand
 
Elmar Schnee
Elmar Schnee  
Head of the Pharmaceuticals business sector
Elmar Schnee
Born in 1959, Business graduate
joined Merck in 2003, Member of the Executive Board since November 2005
Responsibility for Group-wide functions:
Pharmaceuticals business sector
Regional responsibility:
Europe; United States (Pharmaceuticals); Canada; Latin and Central America; Africa; Middle East
 

SERVICES